Urogenital Neoplasms  >>  epirubicin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00096304: Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Terminated
1
36
US
docetaxel, epirubicin hydrochloride
Medical University of South Carolina
Prostate Cancer
09/06
11/07

Download Options